Pharmaceutical - Pharmaceutical, Vaccines

Filter

Current filters:

PharmaceuticalVaccines

Popular Filters

1 to 25 of 218 results

Vaccines a $25.5 billion business in 2014; report

Vaccines a $25.5 billion business in 2014; report

13-02-2015

Vaccines are a big business, and a growing business, says health care market researcher Kalorama Information,…

GlaxoSmithKlineMarkets & MarketingMerck & CoNovartisPfizerPharmaceuticalSanofiVaccines

UPDATE: GSK acquires remainder of GlycoVaxyn for $190 million

UPDATE: GSK acquires remainder of GlycoVaxyn for $190 million

11-02-2015

UK pharma major GlaxoSmithKline this morning said that it has acquired Switzerland-based GlycoVaxyn,…

GlaxoSmithKlineGlycoVaxynMergers & AcquisitionsPharmaceuticalVaccines

CHMP issues positive opinion on new schedule for Sanofi Pasteur's Hexyon

CHMP issues positive opinion on new schedule for Sanofi Pasteur's Hexyon

09-02-2015

The European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion on an…

EuropeHexyonPharmaceuticalRegulationSanofi PasteurSanofi Pasteur MSDVaccines

MSF hits out at Pfizer's 'tiny' price reduction on Prevenar 13 in developing countries

MSF hits out at Pfizer's 'tiny' price reduction on Prevenar 13 in developing countries

27-01-2015

US pharma giant Pfizer has announced commitments to reduce the price of Prevenar 13 (pneumococcal polysaccharide…

Medecins Sans FrontiersPfizerPharmaceuticalPrevenarPricingVaccines

Novartis’ meningitis B vaccine Bexsero approved by US FDA

Novartis’ meningitis B vaccine Bexsero approved by US FDA

24-01-2015

On Friday, the US Food and Drug Administration granted accelerated approval of Swiss pharma giant Novartis’…

BexseroNovartisPharmaceuticalRegulationUSAVaccines

Milestone for GSK/NIH candidate Ebola vaccine as first doses shipped for Phase III trial

Milestone for GSK/NIH candidate Ebola vaccine as first doses shipped for Phase III trial

23-01-2015

UK pharma major GlaxoSmithKline said this morning that the first batch of its candidate Ebola vaccine…

EbolaGlaxoSmithKlinePharmaceuticalResearchUKVaccines

Success of India-developed meningitis A vaccine MenAfriVac

Success of India-developed meningitis A vaccine MenAfriVac

20-01-2015

Meningitis A, that threatens the lives of 450 million people across 26 countries in Africa's ‘Meningitis…

HealthcareIndiaMenAfriVacPharmaceuticalSerum Institute of IndiaSub-Saharan AfricaVaccines

MSF calls on GSK and Pfizer to slash pneumo vaccine price to $5

MSF calls on GSK and Pfizer to slash pneumo vaccine price to $5

20-01-2015

Médecins Sans Frontières (MSF) has called on UK pharma major GlaxoSmithKline and US pharma giant Pfizer…

GlaxoSmithKlineMSFPfizerPharmaceuticalPricingRest of the WorldVaccinationVaccines

Janssen among groups in Innovative Medicines Initiative consortia to accelerate Ebola program

Janssen among groups in Innovative Medicines Initiative consortia to accelerate Ebola program

19-01-2015

US health care giant Johnson & Johnson’s Europe-based subsidiary has formed consortia with several…

Anti-viralsEuropeJanssenPharmaceuticalResearchVaccines

The first Sabin IPV approved by China FDA

19-01-2015

The China Food and Drug Administration (CFDA) on January 14 approved the production of the first inactivated…

ChinaPharmaceuticalProductionRegulationVaccines

Valneva to acquire Dukoral vaccine from Crucell

07-01-2015

France-based biotech firm Valneva has entered into an agreement with Crucell Holland (part of Johnson…

CrucellDukoralJohnson & JohnsonMergers & AcquisitionsPharmaceuticalVaccinesValneva

Overall safety of measles-mumps-rubella-varicella vaccine confirmed by 12-year study

Overall safety of measles-mumps-rubella-varicella vaccine confirmed by 12-year study

06-01-2015

A 12-year study published in the journal Pediatrics has confirmed the safety of two measles-containing…

MedicinePharmaceuticalResearchVaccine Study CenterVaccines

Merck and NewLink Ebola vaccine trial to resume after suspension

Merck and NewLink Ebola vaccine trial to resume after suspension

06-01-2015

The Phase I trial of pharma giant Merck & Co’s Ebola vaccine VSV-ZEBOV, developed in conjunction with…

Merck & CoNewLink GeneticsPharmaceuticalResearchSwitzerlandVaccinesVSV-ZEBOV

Pfizer gains rights to CMV vaccine with controlling stake in Redvax

Pfizer gains rights to CMV vaccine with controlling stake in Redvax

06-01-2015

US pharma giant Pfizer has acquired a controlling interest in Redvax GmbH, a spin-off from Redbiotec,…

Anti-viralsMergers & AcquisitionsPfizerPharmaceuticalRedbiotechRedvaxVaccines

GSK shingles vaccine candidate meets Ph III primary endpoint

GSK shingles vaccine candidate meets Ph III primary endpoint

18-12-2014

UK pharma major GlaxoSmithKline today released pivotal Phase III study data to assess the efficacy of…

AgenusAnti-viralsGlaxoSmithKlineHZ/suPharmaceuticalResearchVaccines

China's Ebola vaccine enters clinical trials

China's Ebola vaccine enters clinical trials

18-12-2014

An Ebola vaccine developed by a military-tied research institute has been approved to enter the human…

Anti-viralsChinaPharmaceuticalResearchVaccines

Sanofi Pasteur gains FDA approval of Fluzone Intradermal Quadrivalent for adults

Sanofi Pasteur gains FDA approval of Fluzone Intradermal Quadrivalent for adults

13-12-2014

French pharma major Sanofi’s vaccines division, Sanofi Pasteur, has received approval from the US Food…

Anti-viralsFluzonePharmaceuticalRegulationSanofiSanofi PasteurUSAVaccines

Merck’s new Gardasil 9 gains backing from US FDA

Merck’s new Gardasil 9 gains backing from US FDA

11-12-2014

The US Food and Drug Administration yesterday approved pharma giant Merck & Co’s Gardasil 9-valent…

Gardasil 9Merck & CoOncologyPharmaceuticalRegulationUSAVaccines

EMA committee concludes no evidence Fluad caused deaths

EMA committee concludes no evidence Fluad caused deaths

04-12-2014

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has concluded that…

EuropeFluadNovartisPharmaceuticalRegulationVaccines

FTC puts conditions on GSK/Novartis consumer JV

27-11-2014

The US Federal Trade Commission has voted to approve UK pharma giant GlaxoSmithKline’s proposed acquisition…

Dr Reddy's LaboratoriesGlaxoSmithKlineHabitrolMergers & AcquisitionsNicodermNovartisPharmaceuticalRegulationUSAVaccines

Sanofi showcases next wave of medicines and vaccines

20-11-2014

French pharma major Sanofi is today outlining its intention to launch high-potential new medicines and…

Cardio-vascularDiabetesHealth Medical PharmaImmunologicalsNeurologicalPharmaceuticalPharmaceutical industryRare diseasesResearchSanofiUnited StatesVaccines

Hilleman Labs signs MoU to fast track development of high-impact oral cholera vaccine

14-11-2014

Hilleman Laboratories, an equal joint-venture partnership between US pharma major Merck & Co and the…

Asia-PacificHilleman LaboratoriesIncepta VaccineMerck & CoPharmaceuticalResearchTropical diseasesVaccinesWELLCOME TRUST

US lawmakers introduce Bill to speed Ebola treatments development

30-10-2014

Two US Senators have announced their intention to introduce a bill to speed the development of treatments…

Anti-viralsLegalPharmaceuticalResearchTropical diseasesUSAVaccines

1 to 25 of 218 results

COMPANY SPOTLIGHT

Menarini

Back to top